|
|
China's pharmarceutical watchdog vows to tighten approval procedures |
 |
+ |
- |
21:21, July 11, 2007 |
China''s pharmaceutical watchdog will tighten the approval procedures for new medicines with the revised regulation on medicine registration taking effect on Oct. 1.
Wu Zhen, deputy-director of the State Food and Drug Administration (SFDA), made the remarks on Wednesday at the SFDA''s first regular press conference.
Wu said the SFDA would take stricter measures to check drugs under approval, including intensifying examinations of production, spot testing samples, and re-examining drugs already on market.
The current regulation on medicine registration came into effect on May 1, 2005.
"Before its revision, the regulation allowed for lax monitoring and examination of production," Wu said.
"Application documents have been inadequate and there have even been serious forgery problems, so it''s pretty hard to ensure the safety of drugs," Wu said.
[1] [2]
|
|
|
Comment
Tell A Friend
Print Format
Save Article